Rhythm Biosciences Limited (FRA:0RY)
0.0810
-0.0290 (-26.36%)
At close: Jan 30, 2026
Rhythm Biosciences Market Cap
Rhythm Biosciences has a market cap or net worth of €27.92 million as of January 30, 2026. Its market cap has increased by 90.66% in one year.
Market Cap
27.92M
Enterprise Value
27.70M
Revenue
1.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.08
Market Cap Chart
Since December 7, 2017, Rhythm Biosciences's market cap has increased from 20.89M to 27.92M, an increase of 33.63%. That is a compound annual growth rate of 3.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 27.92M | 11.63% |
| Dec 31, 2025 | 25.01M | 69.56% |
| Dec 31, 2024 | 14.75M | -19.89% |
| Dec 29, 2023 | 18.41M | -86.53% |
| Dec 30, 2022 | 136.73M | -33.97% |
| Dec 31, 2021 | 207.06M | 86.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 36.86M |
| OTRS AG | 36.22M |
| edding AG | 35.48M |
| Readcrest Capital AG | 32.13M |
| Weng Fine Art AG | 29.35M |
| Biomark Diagnostics | 29.00M |
| Rubean AG | 27.29M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.25M |